Key result
Systemic chemotherapy successfully treated primary cardiac B-cell lymphoma, leading to the complete resolution of atrial fibrillation and bradycardia and restoration of normal sinus rhythm.
Population
A 53-year-old woman presenting with dyspnea, atrial fibrillation, and primary cardiac B-cell lymphoma (n=1).
Design
Case_report
Authors
Loading...
Chemotherapy may reverse AF in primary cardiac lymphoma; leaves open prospective validation in larger cohorts.
Case Report (n=1)
No
Primary cardiac lymphoma is a rare but potentially reversible cause of atrial fibrillation if treated promptly with chemotherapy.
Hishikari et al. (2016) conducted a case report in Primary Cardiac B-Cell Lymphoma (n=1). Systemic chemotherapy was evaluated on Restoration of normal sinus rhythm and tumor regression. Systemic chemotherapy successfully treated primary cardiac B-cell lymphoma, leading to the complete resolution of atrial fibrillation and bradycardia and restoration of normal sinus rhythm.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: